Before the introduction of granulocyte colony‐stimulating factor (G‐CSF) for the treatment of neutropenia in the 1980s, only few individuals with GSD Ib survived into adulthood, while nowadays, with improved treatment strategies, most patients reach adulthood and the child‐bearing age. This evidence concerns the gene CSF3 and neutropenia.